NCT07053709View on ClinicalTrials.gov

Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD)

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

November 1, 2026

Study Completion Date

November 1, 2027

Conditions

Hyperuricemia and MAFLD

All Listed Sponsors

lead

Assiut University

OTHER

NCT07053709 - Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) | Biotech Hunter | Biotech Hunter